Dr. Chaudhary is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
785 Medical Center Drive West
Suite 203
Clovis, CA 93611Phone+1 559-387-1900Fax+1 559-387-1950
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1997 - 2000
- Indiana University School of MedicineResidency, Internal Medicine, 1994 - 1997
- Aga Khan Medical CollegeClass of 1992
Certifications & Licensure
- CA State Medical License 2009 - 2024
- SC State Medical License 2000 - 2009
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer Start of enrollment: 2003 Sep 01
- Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer Start of enrollment: 2001 Nov 01
- PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 2002 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsFinasteride.Uzair B Chaudhary, Jeffrey S Turner
Expert Opinion on Drug Metabolism & Toxicology. 2010-07-01 - 21 citationsBRIP-1 germline mutation and its role in colon cancer: presentation of two case reports and review of literatureMir Ali, Celia D. DeLozier, Uzair B. Chaudhary
BMC Medical Genetics. 2019-05-07 - 100 citationsLong-Term Complications of Chemotherapy for Germ Cell TumoursUzair B. Chaudhary, Jason R Haldas
Drugs. 2003-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: